MARKET

ZBH

ZBH

Zimmer Biomet
NYSE
119.43
+0.10
+0.08%
After Hours: 119.43 +0.02 +0.01% 16:09 04/19 EDT
OPEN
119.90
PREV CLOSE
119.33
HIGH
120.15
LOW
118.99
VOLUME
1.30M
TURNOVER
0
52 WEEK HIGH
149.25
52 WEEK LOW
101.61
MARKET CAP
24.54B
P/E (TTM)
24.46
1D
5D
1M
3M
1Y
5Y
What's in the Cards for Zimmer Biomet (ZBH) in Q1 Earnings?
NASDAQ · 19h ago
Zimmer Biomet Holdings (NYSE:ZBH investor three-year losses grow to 26% as the stock sheds US$1.5b this past week
Simply Wall St · 2d ago
RBC Capital Sticks to Their Buy Rating for Zimmer Biomet Holdings (ZBH)
TipRanks · 3d ago
BUZZ-U.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
The Nasdaq and the S&P 500 were muted on Tuesday as higher Treasury yields pressured equities. The blue-chip Dow bucked the trend on robust results from health insurance heavyweight UnitedHealth. The Dow Jones Industrial Average was up 0.13% at 37,783.35. UnitedHealth Group's quarterly results beat expectations.
Reuters · 3d ago
BUZZ-Medical device makers fall after J&J's medtech unit misses sales estimates
Shares of medical device makers fall between 1% and 3% after Johnson & Johnson's JNJ.N medical devices unit reports Q1 sales of $7.82 bln. Analysts point to weakness in JNJ's vision care products and surgical devices. Stryker, Zimmer Biomet and Medtronic among those down.
Reuters · 3d ago
UPDATE 5-J&J's medical device sales fall short, cancer drugs seen growing
J&J's medical device sales fall short, cancer drugs seen growing. Sales of psoriasis drug Stelara come in lower than expected. The company's large medical devices business reported $7.82 billion in sales for first quarter. J&J shares were down 1.3% in after-hours trading.
Reuters · 3d ago
BUZZ-Truist bets on a 'beat & raise' Q1 for some med-tech players
Brokerage Truist Securities expects Q1 results beat and forecast raises for medical device makers Boston Scientific Corp BSX.N and Intuitive Surgical. Truist believes medical-technology sector will see rising earnings this quarter. Medical device makers have been benefitting from a resurgence in demand for joint replacements.
Reuters · 4d ago
First Week of April 19th Options Trading For Zimmer Biomet Holdings (ZBH)
NASDAQ · 4d ago
More
About ZBH
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.

Webull offers Zimmer Biomet Holdings Inc stock information, including NYSE: ZBH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZBH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZBH stock methods without spending real money on the virtual paper trading platform.